Prevalence of sarcopenia in COPD patients using AWGS criteria among Asian populations: a systematic review and meta-analysis

医学 肌萎缩 慢性阻塞性肺病 共病 优势比 置信区间 内科学 子群分析 生活质量(医疗保健) 荟萃分析 多元分析 物理疗法 肺病 流行 横断面研究 逻辑回归 梅德林 风险评估 疾病严重程度 疾病负担 流行病学 老年学 可能性
作者
Yogesh Murugan,Vaibhavkumar N. Shrivastav,Hari Krishna Akurathi
出处
期刊:BMC Pulmonary Medicine [BioMed Central]
卷期号:26 (1): 406- 被引量:3
标识
DOI:10.1186/s12890-026-04452-3
摘要

BACKGROUND: Sarcopenia is a critical comorbidity in chronic obstructive pulmonary disease (COPD), yet prevalence estimates in Asian populations using standardized Asian Working Group for Sarcopenia (AWGS) criteria remain uncertain. This review aimed to determine pooled sarcopenia prevalence in Asian COPD patients using AWGS criteria, compare AWGS-2014 versus AWGS-2019 estimates, and identify associated risk factors. METHODS: We systematically searched eight databases from inception to December 2024 for studies reporting sarcopenia prevalence in Asian COPD patients using AWGS-2014 or AWGS-2019 criteria. Pooled prevalence with 95% confidence intervals (CI) was calculated using random-effects meta-analysis with Freeman-Tukey double arcsine transformation. Quality was assessed using the Newcastle-Ottawa Scale. Subgroup analyses compared AWGS versions, and pooled odds ratios were calculated to examine risk factors. The review was registered with PROSPERO (CRD420251274827). RESULTS: Ten studies encompassing 2,371 COPD patients from five Asian countries were included. Eight studies used AWGS-2019, and two used AWGS-2014. Overall, the pooled sarcopenia prevalence was 31% (95% CI: 22-41%) with substantial heterogeneity (I²=89.9%). Individual study prevalence ranged from 9.5% to 52.5%. Subgroup analysis revealed no significant difference between AWGS-2014 (30%, 95% CI: 24-38%) and AWGS-2019 (31%, 95% CI: 22-42%) criteria (p = 0.916). All studies demonstrated high methodological quality (NOS scores: 8-10/10). Three independent risk factors were identified: older age (OR: 1.05 per year, 95% CI: 1.03-1.07), low BMI < 18.5 kg/m² (OR: 3.12, 95% CI: 1.98-4.92), and severe COPD stages 3-4 (OR: 2.74, 95% CI: 1.89-3.97). CONCLUSIONS: Approximately one-third of Asian COPD patients have sarcopenia, with comparable prevalence between AWGS versions. Findings support routine screening in high-risk subgroups and integrated care pathways addressing respiratory and musculoskeletal manifestations.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ysf完成签到,获得积分10
1秒前
2秒前
NexusExplorer的应助被平生采纳,获得10
3秒前
王火火完成签到 ,获得积分10
3秒前
邓先桂发布了新的文献求助20
3秒前
科研通AI65的应助被DW采纳,获得10
3秒前
laola发布了新的文献求助10
4秒前
张博雅完成签到,获得积分10
5秒前
terrell完成签到,获得积分10
5秒前
5秒前
勤恳问薇完成签到 ,获得积分10
6秒前
万能图书馆的应助被Chris采纳,获得10
7秒前
kangkang发布了新的文献求助10
7秒前
chen完成签到,获得积分10
7秒前
7秒前
8秒前
活泼大侠完成签到,获得积分10
8秒前
10秒前
麋路完成签到,获得积分10
10秒前
kento的应助被123采纳,获得150
10秒前
13秒前
雾昂完成签到,获得积分10
14秒前
laola完成签到,获得积分10
14秒前
Drcai发布了新的文献求助10
14秒前
852的应助被DW采纳,获得10
14秒前
科目三的应助被業業采纳,获得10
15秒前
gxy完成签到 ,获得积分10
16秒前
体贴电话完成签到,获得积分20
16秒前
16秒前
贾贡献的应助被直率翠绿采纳,获得10
16秒前
18秒前
SciGPT的应助被可妍昇采纳,获得10
18秒前
19秒前
mengchen88完成签到 ,获得积分10
19秒前
邓先桂完成签到,获得积分10
22秒前
charry发布了新的文献求助10
22秒前
22秒前
22秒前
万能图书馆的应助被米娅采纳,获得10
23秒前
初景的应助被niko采纳,获得20
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188249
求助须知:如何正确求助?哪些是违规求助? 9576071
关于积分的说明 21845183
捐赠科研通 7786256
什么是DOI,文献DOI怎么找? 3435261
关于科研通互助平台的介绍 2559559
邀请新用户注册赠送积分活动 2482169